Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ligand Pharm (NQ: LGND )

102.09 +2.33 (+2.34%)
Streaming Delayed Price Updated: 1:23 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,603
Open 100.33
Bid (Size) 102.00 (2)
Ask (Size) 102.38 (1)
Prev. Close 99.76
Today's Range 98.04 - 102.16
52wk Range 49.24 - 101.92
Shares Outstanding 16,676,532
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
5 Best Short-Term Stocks to Consider Investing In
Looking for the best short-term stocks? Explore our top picks and learn how to navigate the risks and opportunities in fast-paced stock trading. 
Via MarketBeat
Ligand to Acquire APEIRON Biologics AG for $100 Million
From Ligand Pharmaceuticals Incorporated
Via Business Wire

Performance

YTD
+41.18%
+41.18%
1 Month
+28.59%
+28.59%
3 Month
+48.97%
+48.97%
6 Month
+39.11%
+39.11%
1 Year
+53.38%
+53.38%

More News

Read More
Lifecore Biomedical Announces Cooperation Agreement with 22NW
From Lifecore Biomedical, Inc.
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About Ligand Pharmaceuticals
Via Benzinga
Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Ligand to Participate in Upcoming Investor Conferences
From Ligand Pharmaceuticals Incorporated
Via Business Wire
3 Magnificent Growth Stocks to Buy Hand Over Fist
Via The Motley Fool
Topics Economy
Exposures Interest Rates
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
Via InvestorPlace
LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Ligand Reports First Quarter 2024 Financial Results
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Don't Overlook These Top Medical Stocks As Q1 Earnings Approach
Via Talk Markets
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
From Ligand Pharmaceuticals Incorporated
Via Business Wire
7 Small-Cap Stocks for the Thinking Speculator
Via InvestorPlace
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Why Is Ligand Pharmaceuticals Stock Trading Higher Today?
Via Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.